ストックスクリーナーアプリを入手
5.94
2.62%
-0.16
アフターアワーズ：
5.93
-0.01
-0.17%
前日終値:
$6.10
開ける：
$6.07
24時間の取引高:
144.18K
Relative Volume:
0.59
時価総額：
$219.93M
収益：
$128.45M
当期純損益:
$6.54M
株価収益率:
118.80
EPS:
0.05
ネットキャッシュフロー:
$-8.79M
1週間 パフォーマンス:
-6.01%
1か月 パフォーマンス:
-20.05%
6か月 パフォーマンス:
-6.16%
1年 パフォーマンス:
-9.04%
1日の値動き範囲:
$5.87
$6.11
1週間の範囲:
$5.795
$6.35
52週間の値動き範囲:
$3.6793
$8.90
Lifecore Biomedical Inc Stock (LFCR) Company Profile
LFCR を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
LFCR
Lifecore Biomedical Inc
|
5.94 | 219.93M | 128.45M | 6.54M | -8.79M | 0.05 |
|
ZTS
Zoetis Inc
|
170.90 | 77.10B | 9.15B | 2.43B | 2.31B | 5.32 |
|
HLN
Haleon Plc Adr
|
9.47 | 42.82B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.39 | 42.45B | 30.27B | 1.93B | 3.45B | 0.6044 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.73 | 20.09B | 16.77B | -959.00M | 1.37B | -0.85 |
|
NBIX
Neurocrine Biosciences Inc
|
151.82 | 15.37B | 2.24B | 385.90M | 440.10M | 3.73 |
Lifecore Biomedical Inc Stock (LFCR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-09-05 | 開始されました | Craig Hallum | Buy |
| 2024-08-28 | ダウングレード | Barrington Research | Outperform → Mkt Perform |
| 2023-03-20 | ダウングレード | Stephens | Overweight → Equal-Weight |
Lifecore Biomedical Inc (LFCR) 最新ニュース
(LFCR) Investment Analysis - Stock Traders Daily
Lifecore Biomedical’s Earnings Call: Growth Amid Challenges - TipRanks
This Lifecore Biomedical Insider Increased Their Holding In The Last Year - Yahoo Finance
Lifecore Biomedical, Inc. (NASDAQ:LFCR) Shares Purchased by Barclays PLC - Defense World
Here are Laughing Water Capital’s Updates on Lifecore Biomedical (LFCR) - Insider Monkey
(LFCR) Technical Data - Stock Traders Daily
Lifecore Biomedical, Inc. (NASDAQ:LFCR) Sees Significant Increase in Short Interest - Defense World
Lifecore Biomedical, Inc. (NASDAQ:LFCR) Short Interest Update - MarketBeat
Lifecore Biomedical Announces Special Stockholder Meeting - The Manila Times
Lifecore Biomedical Calls Special Meeting to Vote on Preferred Stock Conversion Cap Removal - StockTitan
Jane Street Group LLC Increases Position in Lifecore Biomedical, Inc. (NASDAQ:LFCR) - Defense World
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lifecore Biomedical, Inc. (LFCR) And Encourages Shareholders to Reach Out - AccessWire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Shareholders to Learn More About the Investigation - AccessWire
LFCR FY2025 EPS Forecast Boosted by Barrington Research - Defense World
Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - AccessWire
LFCR FY2025 EPS Forecast Lifted by Barrington Research - MarketBeat
Paul Josephs Bought 3.1% More Shares In Lifecore Biomedical - Simply Wall St
Bronstein, Gewirtz & Grossman, LLC Is Investigating Lifecore Biomedical, Inc. (LFCR) And Encourages Investors to Connect - AccessWire
Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - AccessWire
Lifecore Biomedical, Inc. (NASDAQ:LFCR) CEO Paul Josephs Acquires 17,000 Shares - MarketBeat
Geode Capital Management LLC Increases Position in Lifecore Biomedical, Inc. (NASDAQ:LFCR) - Defense World
Barclays PLC Has $147,000 Stock Position in Lifecore Biomedical, Inc. (NASDAQ:LFCR) - Defense World
Lifecore Biomedical to sell multi-purpose 10-head isolator filler - MSN
Lifecore Biomedical Sells Excess Capital Equipment for $17M - Contract Pharma
Lifecore Biomedical Further Strengthens Financial Position Through Sale of Excess Capital Equipment for $17 Million - The Manila Times
Lifecore Biomedical Secures $17M Equipment Sale, Doubles Production Capacity with New Filler - StockTitan
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Investors to Learn More About the Investigation - AccessWire
Lifecore Biomedical to Participate at 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times
LFCR Stock Earnings: Lifecore Biomedical Beats EPS, Beats Revenue for Q2 2024 - MSN
LFCR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces an Investigation into Lifecore Biomedical, Inc. and Encourages Investors to Contact the Firm - AccessWire
Lifecore Biomedical, Inc. (NASDAQ:LFCR) Q2 2025 Earnings Call Transcript - MSN
Lifecore Biomedical’s (LFCR) “Equal Weight” Rating Reaffirmed at Stephens - Defense World
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lifecore Biomedical, Inc. (LFCR) And Encourages Stockholders to Reach Out - AccessWire
Lifecore stock reaffirmed at Equal Weight at Stephens following Q2 results By Investing.com - Investing.com Canada
Lifecore Biomedical's (LFCR) "Equal Weight" Rating Reaffirmed at Stephens - MarketBeat
Further weakness as Lifecore Biomedical (NASDAQ:LFCR) drops 11% this week, taking three-year losses to 38% - Simply Wall St
US Stocks Poised To Open Higher As Futures Advance: Tesla, Bumble, Lifecore Bio In Focus - Benzinga
Lifecore Biomedical: Fiscal Q2 Earnings Snapshot - Midland Daily News
Resources Connection, SPS Commerce And 3 Stocks To Watch Heading Into Friday - Benzinga
Lifecore Biomedical Inc (LFCR) Q2 2025 Earnings Call Highlights: Revenue Growth Amidst Rising ... By GuruFocus - Investing.com Canada
Earnings call transcript: Lifecore Biomedical Q2 2024 sees revenue growth, stock dips - Investing.com Australia
Lifecore Biomedical Reports Q2 Fiscal 2025 Results - TipRanks
Lifecore Biomedical Inc (LFCR) Q2 Fiscal 2025 Earnings: EPS Loss - GuruFocus.com
Lifecore Biomedical earnings beat by $0.02, revenue topped estimates - Investing.com Canada
Lifecore Biomedical, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended November 24, 2024 - Marketscreener.com
Lifecore Biomedical (LFCR) Reports Q2 Loss, Tops Revenue Estimates - MSN
Stocks to Watch: Lifecore Biomedical, Resources Connection - MarketWatch
Lifecore Biomedical Inc. (LFCR) reports earnings - Quartz
Lifecore Biomedical (NASDAQ:LFCR) Issues Earnings Results - MarketBeat
Lifecore Biomedical Inc (LFCR) 財務データ
収益
当期純利益
現金流量
EPS
1.19%
0.06%
大文字化:
|
ボリューム (24 時間):